Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,206.00    32.00 (1.47%)
Bid:
2,186.00
Ask:
2,200.00
Spread: 14.00 (0.64%)
Market Cap: £1.47b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

22 Sep 2010 14:49

RNS Number : 1319T
Genus PLC
22 September 2010
 

22 September 2010

 

Genus plc

 

('Genus' or 'the Company')

 

Director/PDMR Shareholding

 

 

Genus announces that conditional nil-cost share options were granted under the Genus 2004 Performance Share Plan ("the Plan") today to Richard Wood, Chief Executive, as to 57,631 ordinary shares of 10 pence each in the Company ("Ordinary Shares"). These options are subject to performance conditions which relate to growth in the Company's earnings per share over a three year period and which trigger vesting on an incremental basis.

 

Genus further announces that of 154,639 Ordinary Shares that vested today in favour of Richard Wood, Chief Executive, under the Plan, 154,639 Ordinary Shares were today sold on behalf of Richard Wood at a price of 770 pence per Ordinary Share.

 

Richard Wood's direct shareholding in the Company stands at 60,856 Ordinary Shares which represents 0.102% of the issued share capital of the Company which is currently 59,678,535 Ordinary Shares. In addition, he remains the beneficial owner of 195,457 conditional nil-cost options under the Plan.

 

Genus also announces that of 34,364 Ordinary Shares that vested today in favour of Ian Biggs, Head of Global Product & Business Strategy, under the Plan, 34,364 Ordinary Shares were today sold on behalf of Ian Biggs at a price of 770 pence per Ordinary Share. Ian Biggs' direct shareholding in the Company stands at 3,375 Ordinary Shares which represents 0.006% of the issued share capital of the Company. In addition, he remains the beneficial owner of 109,530 conditional nil-cost options under the Plan.

 

Of 33,505 Ordinary Shares that vested today in favour of Thomas Philip Acton, Chief Operating Officer of Europe & The Far East, under the Plan, 33,505 Ordinary Shares were today sold on behalf of Thomas Philip Acton at a price of 770 pence per Ordinary Share.

Thomas Philip Acton's direct shareholding in the Company stands at 21,104 Ordinary Shares which represents 0.035% of the issued share capital of the Company. In addition, he remains the beneficial owner of 103,084 conditional nil-cost options under the Plan.

 

Of 17,182 Ordinary Shares that vested today in favour of Ian Farrelly, Group Company Secretary & General Counsel, under the Plan, 17,182 Ordinary Shares were today sold on behalf of Ian Farrelly at a price of 770 pence per Ordinary Share. Ian Farrelly has no direct shareholding in the Company. He remains the beneficial owner of 75,018 conditional nil-cost options under the Plan.

 

 

For further information please contact:

 

Cara Crichton

Company Secretarial Assistant

Genus plc

 

Tel: 01256 345996

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUUSORRWAKUAR
Date   Source Headline
27th Feb 20257:00 amRNSInterim Results
26th Feb 20257:00 amRNSNon-Executive Director Retirement
3rd Feb 20253:17 pmRNSBlock Listing Six Monthly Return
3rd Feb 20259:40 amRNSTotal Voting Rights
15th Jan 20257:00 amRNSHalf Year Trading Update – Ahead of expectations
12th Dec 20245:07 pmRNSNotification of Major Holdings
20th Nov 20243:32 pmRNSResults of AGM
20th Nov 20247:00 amRNSAGM Trading Update
1st Nov 202410:42 amRNSTotal Voting Rights
22nd Oct 20247:00 amRNSChief Financial Officer Retirement
14th Oct 20247:00 amRNSAnnual Report and Annual General Meeting
18th Sep 202411:17 amRNSDirector/PDMR Shareholding
16th Sep 20244:29 pmRNSDirector/PDMR Shareholding
12th Sep 20244:51 pmRNSDirector/PDMR Shareholding
12th Sep 20247:00 amRNSDirector/PDMR Shareholding
9th Sep 20247:00 amRNSDirector/PDMR Shareholding
6th Sep 202412:31 pmRNSDirector/PDMR Shareholding
6th Sep 202412:30 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSPreliminary Results
1st Aug 20244:26 pmRNSBlock Listing Six Monthly Return
1st Aug 20243:38 pmRNSTotal Voting Rights
17th Jul 20247:00 amRNSTrading Update
3rd Jun 202410:48 amRNSHolding(s) in Company
1st May 20241:59 pmRNSTotal Voting Rights
22nd Feb 20247:00 amRNSInterim Results
15th Feb 20247:00 amRNSTrading Update
1st Feb 20244:24 pmRNSBlock listing Interim Review
1st Feb 20244:21 pmRNSTotal Voting Rights
12th Dec 20237:00 amRNSNon-Executive Director Appointment
22nd Nov 20231:08 pmRNSResult of AGM
22nd Nov 20237:00 amRNSAGM Trading Update
1st Nov 20234:46 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSCapital Markets Event
13th Oct 20237:00 amRNSAnnual Report and Annual General Meeting
5th Oct 202310:19 amRNSPos. determination-PRRS resistant pigs-Colombia
2nd Oct 202311:12 amRNSTotal Voting Rights
15th Sep 20231:07 pmRNSDirector/PDMR Shareholding
15th Sep 202310:04 amRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSPreliminary Results
25th Aug 20238:35 amRNSNotification of Major Holdings
23rd Aug 20239:25 amRNSDirectorate Change
1st Aug 202311:41 amRNSBlock listing Interim Review
1st Aug 202311:36 amRNSTotal Voting Rights
3rd Jul 202311:02 amRNSTotal Voting Rights
16th Jun 20235:33 pmRNSNational Milk Records plc - Form 8.3
16th Jun 20235:10 pmRNSForm 8.3 (OPD) - National Milk Records plc
8th Jun 20233:51 pmRNSDirector/PDMR Shareholding
7th Jun 20235:11 pmRNSNotification of Major Holdings
7th Jun 20235:08 pmRNSNotification of Major Holdings
5th Jun 20239:12 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.